Lumanity

Lumanity engineers breakthrough value for life sciences companies, combining deep expertise and purpose-built AI to accelerate and optimize access to life-saving medicines, with end-to-end commercialization support from initial strategy to market execution. Its products include Lumanity Illuminator, its AI-enabled intelligence platform, the Ignite platform for aligning cross-functional workstreams, the ONEE omnichannel engagement solution, Sonar social listening reports, WeConvEEn and Engage.

Market Access, HEOR and Brand Strategy

• Plan market access and launch strategy using landscape assessments, policy mapping, payer insights, reimbursement strategy and market access plans.
• Build health economic models across drug development stages, synthesize evidence, conduct indirect treatment comparisons, and support HEOR strategy and HTA submissions, including payer-facing value dossiers and communications. Market access work also includes pricing expertise across the product life cycle, and RWE combined with health economics and comparative effectiveness for access planning. Evidence synthesis and HTA work covers systematic and targeted literature reviews, indirect treatment comparisons, and submissions to bodies such as NICE, ICER, CDA-AMC and SMC.

Commercial and Medical Engagement

• Define brand positioning, asset strategy, product launch readiness, market research, competitive intelligence and international market expansion plans.
• Develop scientific communications, publication plans, congress strategies, medical communications content, advisory boards, KOL and stakeholder engagement, and medical affairs strategies and operating plans. Lumanity also supports investigator-sponsored studies, medical affairs project management and impact measurement.

Evidence, Data and Regulatory Operations

• Design RWE strategies and studies using epidemiology, patient pathways, treatment patterns, retrospective analyses, comparative effectiveness, synthetic controls and post-authorization safety and effectiveness studies.
• Use the PHARMO Data Network for multi-setting European real-world data, run pharmacoepidemiology studies through the PHARMO Institute, part of Lumanity, and coordinate multi-country RWE studies for regulators and HTA bodies; its Expert Illuminator platform profiles experts' leadership positions, research interests, social activity, education and payment data.

Engagement, Clinical and Regulatory

• Coordinate omnichannel customer journeys and next-best-action decisioning through the ONEE omnichannel engagement solution, alongside creative campaigns, HCP media planning, patient and consumer marketing, speaker programs and patient support program design.
• Prepare clinical and regulatory programs through protocol optimization, IND and CTA readiness, marketing authorization and lifecycle submissions, agency interactions, GCP and GxP compliance consulting, inspection readiness and SOP development.

Best Fit

• Best suited to pharmaceutical, biotechnology and healthcare teams seeking a consulting and research services partner across market access, HEOR, brand and launch strategy, medical affairs, RWE, regulatory work and commercial engagement.
• Useful where a program requires connected strategy, evidence, analytics, scientific communications and operational support rather than a single specialized service.